CX3CL1 and neoplasm: Although CX3CR1+ CD8+ T cells are present in tumors, it remains unclear whether they directly differentiate from the CX3CR1− subset within the tumor microenvironment or are trafficked from secondary lymphoid organs via the CX3CL1/CX3CR1 chemokine axis.